Evidence map›Paper›PMID 37962789›Full record

ArticleJournal of racial and ethnic health disparities2025

Understanding Sociodemographic Factors among Hispanics Through a Population-Based Study on Testicular Cancer in Mexico.

Juan Alberto Ríos-Rodríguez, Michel Montalvo-Casimiro, Diego Ivar Álvarez-López, Nancy Reynoso-Noverón, Berenice Cuevas-Estrada, Julia Mendoza-Pérez, Miguel A Jiménez-Ríos, Talia Wegman-Ostrosky, Pamela Salcedo-Tello, Anna Scavuzzo and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of racial and ethnic health disparities, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Juan Alberto Ríos-Rodríguez *Unidad de Investigación Biomédica en Cáncer, Instituto Nacional de Cancerología-Instituto de Investigaciones Biomédicas, UNAM, Mexico City, 14080, México.
Michel Montalvo-Casimiro *Unidad de Investigación Biomédica en Cáncer, Instituto Nacional de Cancerología-Instituto de Investigaciones Biomédicas, UNAM, Mexico City, 14080, México.
Diego Ivar Álvarez-LópezUnidad de Epidemiología en Cáncer, Instituto Nacional de Cancerología, Mexico City, 14080, México.
Nancy Reynoso-NoverónUnidad de Investigación Biomédica en Cáncer, Instituto Nacional de Cancerología-Instituto de Investigaciones Biomédicas, UNAM, Mexico City, 14080, México.
Berenice Cuevas-EstradaUnidad de Investigación Biomédica en Cáncer, Instituto Nacional de Cancerología-Instituto de Investigaciones Biomédicas, UNAM, Mexico City, 14080, México.
Julia Mendoza-PérezDepartment of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
Miguel A Jiménez-RíosDepartamento de Urología, Instituto Nacional de Cancerología, Mexico City, 14080, México.
Talia Wegman-OstroskyUnidad de Investigación Biomédica en Cáncer, Instituto Nacional de Cancerología-Instituto de Investigaciones Biomédicas, UNAM, Mexico City, 14080, México.
Pamela Salcedo-TelloDepartamento de Bioquímica, Facultad de Medicina, UNAM, Mexico City, 04510, México.
Anna ScavuzzoDepartamento de Urología, Instituto Nacional de Cancerología, Mexico City, 14080, México.
Clementina Castro-HernándezUnidad de Investigación Biomédica en Cáncer, Instituto Nacional de Cancerología-Instituto de Investigaciones Biomédicas, UNAM, Mexico City, 14080, México.
Luis A HerreraUnidad de Investigación Biomédica en Cáncer, Instituto Nacional de Cancerología-Instituto de Investigaciones Biomédicas, UNAM, Mexico City, 14080, México. herream@biomedicas.unam.mx.
Rodrigo González-BarriosUnidad de Investigación Biomédica en Cáncer, Instituto Nacional de Cancerología-Instituto de Investigaciones Biomédicas, UNAM, Mexico City, 14080, México. rodrigop@ciencias.unam.mx.ORCID 0000-0001-8982-6586
Instituto Nacional de Cancerología · MXThe University of Texas MD Anderson Cancer Center · USUniversidad Nacional Autónoma de México · MX

Funding

Ministry of Health Mexico FPIS-INCAN-4352
6 · The paper itself

Abstract

Testicular cancer (TCa) is a rare malignancy affecting young men worldwide. Sociodemographic factors, especially socioeconomic level (SEL) and healthcare access, seem to impact TCa incidence and outcomes, particularly among Hispanic populations. However, limited research has explored these variables in Hispanic groups. This study aimed to investigate sociodemographic and clinical factors in Mexico and their role in health disparities among Hispanic TCa patients. We retrospectively analyzed 244 Mexican TCa cases between 2007 and 2020 of a representative cohort with diverse social backgrounds from a national reference cancer center. Logistic regression identified risk factors for fatality: non-seminoma histology, advanced stage, and lower education levels. Age showed a significant trend as a risk factor. Patient delay and healthcare distance lacked significant associations. Inadequate treatment response and chemotherapy resistance were more likely in advanced stages, while higher education positively impacted treatment response. Cox regression highlighted non-seminoma histology, below-median SEL, higher education, and advanced-stage survival rates. Survival disparities emerged based on tumor histology and patient SEL. This research underscores the importance of comprehensive approaches that integrate sociodemographic, biological, and environmental factors to address health disparities improving outcomes through personalized interventions in Hispanic individuals with TCa.

Indexed as

Healthcare DisparitiesHealth Status DisparitiesHispanic or LatinoTesticular NeoplasmsAdolescentAdultHealth Services AccessibilityHumansMaleMexicoMiddle AgedRetrospective StudiesRisk FactorsSociodemographic FactorsSocioeconomic FactorsYoung AdultCancer survivalHealth disparitiesHispanic populationIncidence trendsTesticular cancerTGCT

Identifiers

PMID37962789
PMCPMC11753316
OpenAlexW4388655459

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.